Background We conducted a systematic review to compare the effects of pneumatic
vitreolysis (PV), enzymatic vitreolysis (EVL) with ocriplasmin, and pars plana vitrectomy …

Pharmacologic vitreolysis with ocriplasmin, a 27 kilodalton serine protease, is an effective
nonsurgical treatment option for vitreomacular traction (VMT). Data from phase III clinical …

Purpose Vitreous floaters can lower visual acuity (VA) and degrade contrast sensitivity
function (CSF). Limited vitrectomy improves VA and normalizes CSF, but long-term results in …

Epiretinal membranes (ERMs) are sheet-like structures that develop on the inner surface of
the neurosensory retina. Vitreomacular adhesion (VMA) is an attachment of the posterior …

Purpose: To assess the posterior vitreous release rates following a single, office-based
intravitreal injection of expansile gas in treating vitreomacular traction. Methods: Thirty eyes …

BACKGROUND AND OBJECTIVE: To investigate the clinical course and outcomes of
patients with vitreomacular traction (VMT) managed initially by observation. PATIENTS AND …

Purpose To assess how vitreomacular adhesion (VMA), vitreomacular traction (VMT), and
macular holes (MH) evolve, and to assess visual acuity outcomes associated with different …

Purpose: To report the safety of intravitreal ocriplasmin injection based on 2 Phase 3 clinical
trials in patients with symptomatic vitreomacular adhesion/vitreomacular traction, including …

Purpose A computational model of vitreous oxygen consumption and transport predicts that
limited vitrectomy will result in lower retrolental oxygen levels than extensive vitrectomy, and …

Background: Epiretinal membrane (ERM) and vitreomacular traction (VMT) are relatively
common retinal conditions that are predominant in adults. VMT is less common than ERM …